Philip Marlowe

The étoricoxib is new a Coxib. With the the United States, FDA requires additional data concerning safety and the effectiveness of the étoricoxib before authorizing its marketing. The drug is recorded in certain countries of Europe, for example, the the United Kingdom, the Belgium (Arcoxia®), (but neither in France, nor in Suisse)…

Random links: